December 15th, 2015

Investors Snatch BTAI 10.0% Lower Than Its Secondary Stock Offering

Looking back to 93 days ago, BioXcel Therapeutics Inc (BTAI) priced a 4,000,000 share secondary stock offering at $50.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.